NYSE:DOCHealth Care REITs
How Stronger Profitability and New 2026 EPS Guidance Will Impact Healthpeak Properties (DOC) Investors
Healthpeak Properties has reported its fourth-quarter and full-year 2025 results, showing higher quarterly sales and revenue than a year earlier, a sharp rise in quarterly net income, and new 2026 diluted EPS guidance of US$0.34 to US$0.38 per share.
An interesting development for investors is the hiring of former Palantir executive Omkar Joshi as Head of Enterprise Innovation to drive technology, automation and data initiatives across Healthpeak's real estate platform.
Next, we will examine...